SCHEMBL32685014

SCHEMBL32685014

CCCCCCCCCCCCCCCC(=O)Oc1ccc(C(C)(C)C)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
HDAC3 O15379 2/20 0.48
HDAC1 Q13547 2/20 0.48
HDAC2 Q92769 2/20 0.48
MAPT P10636 3/20 0.47
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ESR1 P03372 1/20 0.45
CA2 P00918 2/20 0.44
BCL9 O00512 1/20 0.44
CTNNB1 P35222 1/20 0.44
HTR1A P08908 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32684888 1.00 KMT2A (0.57) KMT2ASMN1; SMN2NPC1RAB9AHDAC3
SCHEMBL31094048 1.00 KMT2A (0.57) KMT2ASMN1; SMN2NPC1RAB9AHDAC3
SCHEMBL11526720 0.98 KMT2A (0.56) KMT2ASMN1; SMN2NPC1RAB9AHDAC3
SCHEMBL27652865 0.98 KMT2A (0.55) KMT2ASMN1; SMN2NPC1RAB9AHDAC3
SCHEMBL28588550 0.94 KMT2A (0.49) KMT2ASMN1; SMN2NPC1RAB9AHDAC3
SCHEMBL9016841 0.91 KMT2A (0.57) KMT2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL15987811 0.91 KMT2A (0.57) KMT2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL15549028 0.88 KMT2A (0.68) KMT2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL5696715 0.88 KMT2A (0.68) KMT2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL38661498 0.88 KMT2A (0.68) KMT2ASMN1; SMN2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260069734-A1 FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS ARYLESSENCE INC (US) 2026-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260069734-A1 FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS FFAR1, FFAR2, FFAR3 KMT2A 3395/4885SMN1; SMN2 4319/4885NPC1 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.